These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25916070)
1. Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis. Dogan S; Celikbilek M; Zararsiz G; Deniz K; Sivgin S; Guven K; Gursoy S; Ozbakir O; Yucesoy M Hepatogastroenterology; 2015; 62(138):393-8. PubMed ID: 25916070 [TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777 [TBL] [Abstract][Full Text] [Related]
3. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759 [TBL] [Abstract][Full Text] [Related]
4. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Cengiz M; Ozenirler S Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268 [TBL] [Abstract][Full Text] [Related]
6. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH). Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763 [TBL] [Abstract][Full Text] [Related]
7. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme. Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777 [TBL] [Abstract][Full Text] [Related]
9. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease. Eng K; Lopez R; Liccardo D; Nobili V; Alkhouri N Dig Liver Dis; 2014 Nov; 46(11):1008-13. PubMed ID: 25106814 [TBL] [Abstract][Full Text] [Related]
10. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis]. Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475 [TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. Jung KY; Cho SY; Kim HJ; Kim SB; Song IH J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936 [TBL] [Abstract][Full Text] [Related]
13. The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters. Chunming L; Jianhui S; Hongguang Z; Chunwu Q; Xiaoyun H; Lijun Y; Xuejun Y Turk J Gastroenterol; 2015 Sep; 26(5):408-16. PubMed ID: 26215061 [TBL] [Abstract][Full Text] [Related]
14. Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study. Chan WK; Ida NH; Cheah PL; Goh KL J Dig Dis; 2014 Oct; 15(10):545-52. PubMed ID: 25060399 [TBL] [Abstract][Full Text] [Related]
15. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Sorbi D; Boynton J; Lindor KD Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476 [TBL] [Abstract][Full Text] [Related]
17. New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan. Kawamura Y; Ikeda K; Arase Y; Sorin Y; Fukushima T; Kunimoto H; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H Hepatol Int; 2015 Apr; 9(2):269-77. PubMed ID: 25788193 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and histological features of non-alcoholic fatty liver disease]. Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Verma S; Jensen D; Hart J; Mohanty SR Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360 [TBL] [Abstract][Full Text] [Related]
20. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]